Abstract
Hypertension has remained the number one cause of cardiovascular death in the Philippines for over three (3) decades. Despite this finding, the burden accounted for by hypertension is investigated to a lesser extent. We performed this study to determine the socioeconomic impact of hypertension in the Philippines, and it was projected in the next 30 years. We gathered primary data through interviews, Labor Force Survey (N = 806), and secondary data from various government published reports. The cost of illness (COI) was calculated using the direct morbidity and mortality costs. The impact (% of respondents) of uncontrolled hypertension on productivity at work showed the following; four (4) days missing work (72%) and ten (10) days lost of productivity (63%). The impact (% of respondents) of uncontrolled hypertension on productivity at home showed the following: six (6) days of household suspended (66%), eleven (11) days reduced household work (78%), and five (5) days affected social activity (60%). The productivity loss of premature mortality accounts for 17% of the total economic burden in 2020 and will increase to 20% by 2050. In 2020, 70% of the total economic burden was accounted for direct & indirect care. At its present value, the economic cost of hypertension is expected to increase from US$1 billion in 2020 to US$1.9 billion by 2050. The socioeconomic impact of uncontrolled hypertension in the Philippines was enormous, challenging, and overwhelming for the next 30 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–80.
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.
Galson SW, Staniffer JW, Hertz JT, Temu G, Thielman N, Gafaar T, et al. The burden of hypertension in the emergency department and linkage tto care: a prospective cohort study in Tanzania. PLoS One 2019;14: https://doi.org/10.1371/journal.pone.0211287. eCollection 2019.
Hird TR, Zomer E, Owen AJ, Magliano DJ, Liew D, Ademi Z. Productivity burden of hypertension in Australia. Hypertension. 2019;73:777–84.
Kothavale A, Pun P, Yadav S The burden of hypertension and unmet need for hypertension care among men aged 15-54 years: a population-based cross-sectional study in India. J Biosoc Sci 20211-22. https://doi.org/10.1017/S0021932021000481.
Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, Laurence C, Aadebamowo C, Ajayi I, et al. The burden of hypertension in sub-Saharan Africa: a four-country cross sectional study. BMC Public Health. 2015;15:1211.
Goswami AK, Gupta SK, Kalaivani M, Nongkynrih B, Pandav CS. Burden of hypertension and diabetes among urban population aged >60 years in South Delhi: a community-based study. J Clin Diagn Res. 2016;10:LC01–5. https://doi.org/10.7860/JCDR/2016/17284.7366. Epub 2016 Mar 1.
Miraglia JL, Mafra ACCN, Monteiro CN, Borges LM. The variation of the burden of hypertension and diabetes in two large districts of the city of Sao Paolo, Brazil, based on primary health care routinely-collected data. PLoS One. 2019;14:e0213998 https://doi.org/10.1371/journal.pone.0213998.
Dereje N, Earsido A, Temam L, Abebe A. Uncovering the high burden of hypertension and its predictors among adult population in Hosanna town, southern Ethiopia: a community-based cross-sectional study. BMJ Open. 2020;10:e035823 https://doi.org/10.1136/bmjopen-2019-035823.
Hajri T, Caceres L, Angamarca-Armijos V. The burden of hypertension in Ecuador: a systematic review and meta-analysis. J Hum Hypertens. 2021;35:389–97.
Keaseley J, Oyebode O, Shantikumar S, Proto W, McGranahan M, Sabouni A, et al. A systematic review of the burden of hypertension in humanitarian crisis settings. BMJ Glob Health. 2020;5:e002440 https://doi.org/10.1136/bmjgh-2020-002440.
Total burden of disease (DALY, YLL and YLD)-states & territories. https://health.act.gov.au/about-our-health-system/data-and-publications/healthstats/statistics-and-indicators/total-burden-0. Accessed 15 August 2022.
Clow B. Burden of disease: what it means and why it matters. https://evidencenetwork.ca/burden-of-disease-what-it-means-and-why-it-matters/. Accessed 15 August 2022.
Stevens B, Pezzullo L, Verdian L, Tomlinson J, Estrada-Aguilar C, George A, et al. economic Burd hypertension, heart Fail, Myocard Infarct, Atr fibrillation Mex. 2018. https://doi.org/10.1016/J.ACMX.2018.03.004. Accessed on 13 August 2022.
Mercado-Asis LB, Atilano AA, Ona DID, Bonzon DD, Vilela GA, Chua CL, et al. Prevalence of hypertension in the Philippines in the year 2050: confronting a major challenge. J Clin Med Res. 2022;3:1–13.
Philippine Statistics Authority. Philippine projection statistics. 2019. https://psa.gov.ph/statistics/census/projected-population. Accessed 26 Dec 2020.
Family Income and Expenditure Survey. https://psa.gov.ph/fies-index. Accessed on 15 August 2022.
National Demographic and Health Survey (NDHS). https://psa.gov.ph/content/national-demographic-and-health-survey-ndhs. Accessed oon 15 August 2022.
Food and Nutrition Research Institute. Expanded National Nutrition Survey (ENNS): 2019 results. http://enutrition.fnri.dost.gov.ph/site/uploads/2019%20ENNS%20Provincial%20Dissemination%20-%20Angeles%20City.pdf.
Institute for health metrics and evaluation. 2019. https://vizhub.healthdata.org/gbd-compare/. Accessed 2 Nov2019.
United Nations Department of Economic and Social Affairs. Population Dynamics. World Population Prospects 2019. https://population.un.org/wpp/. Accessed 8 Oct2021.
World Health Organization. Global health observatory data repository. Raised blood pressure (SBP > 140 or DBP >, crude (%), estimates by country 2017. https://apps.who.int/gho/data/view.main.2464EST?lang=en. Accessed 26 Dec2020.
Cost of Illness. https://www.cdc.gov/policy/polaris/economics/cost-illness/index.html. Accessed on 15 August 2022.
Present Discounted Value. https://philschatz.com/economics-book/contents/m48834.html. Accessed 15 August 2022.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran P, et al. 2020 International Society of Hypertension global hypertension practice guidelines. https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.120.15026 Accessed 15 August 2022.
Jin C-N, Yu C-M, Sun J-P, Fang F, Wen Y-N, Liu M, et al. The healthcare burden of hypertension in Asia. Heart Asia. 2013;5:238–43.
Bhise MD, Patra S. Prevalence and correlates of hypertension in Maharashtra, India: a multilevel analysis. Asia Pac J Public Health. 2019;31:101–12.
Lu JL, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: Data from 1.7 million in a population-based screening study (China PEACE Million Persons Project). Lancet 2017;390:2549–58.
Hisamatsu T, Segawa H, Kadota A, Ohkubo T, Arima H, Miura K. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res. 2020;43:1344–51.
Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18:785–802.
Funding
The study was supported by a research grant from the Philippine Society of Hypertension.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mercado-Asis, L.B., Ona, D.I.D., Bonzon, D. et al. Socioeconomic impact and burden of hypertension in the Philippines projected in 2050. Hypertens Res 46, 244–252 (2023). https://doi.org/10.1038/s41440-022-01052-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-022-01052-6